U.S. chemical abortions as a result of telehealth rise by 25%, report finds

U.S. chemical abortions as a result of telehealth rise by 25%, report finds

<span>U.S. chemical abortions as a result of telehealth rise by 25%, report finds</span> <div class="field field--name-field-post-date field--type-datetime field--label-hidden field--item"><time datetime="2026-03-27T12:00:00Z">Friday, March 27, 2026</time></div> <span><span>CG46414</span></span> <span><time datetime="2026-04-02T12:07:59-04:00" title="Thursday, April 2, 2026">Thursday, April 2, 2026</time></span> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><p>EWTN News </p> <p><strong>U.S. chemical abortions as a result of telehealth rise by 25%, report finds</strong></p> <p><strong><em>Here is a roundup of recent pro-life and abortion-related news.</em></strong></p> <p>By Kate Quiñones</p> <p>The U.S. saw a slight increase in all abortions in 2025 and a more than 25% increase in chemical abortions obtained through telehealth, according to a report from the Guttmacher Institute.</p> <p>There were 1,126,000 total abortions recorded in 2025 in the U.S., a less than 1% increase from 2024.</p> <p>The report concedes, however, that the numbers are an “underestimate” of the total number of abortions nationally because abortions that are not provided by U.S. clinicians are not included.</p> <p>The report also found that women traveled less frequently to obtain an abortion, coinciding with an increase in the number of chemical abortions obtained through telehealth provision.</p> <p>“What’s really concerning is that we see a big increase in telehealth abortions,” Michael New, a scholar at The Catholic University of America, told “EWTN Pro-Life Weekly.” “They found that in states with abortion bans, over 91,000 women obtained abortions by telehealth. That was over a 25% increase from the previous year.”</p> <p>“This really shows telehealth abortions are increasing abortion numbers,” New said. “Putting some limits on these telehealth abortions needs to be a top priority for pro-lifers.”</p> <p><strong>U.S. senators launch investigation into chemical abortion drug manufacturers</strong></p> <p>Five U.S. senators launched an investigation this week into chemical abortion drug manufacturers’ compliance with FDA safeguards, urging the FDA to take action on issues surrounding chemical abortions obtained through telehealth.</p> <p>Led by Sen. Bill Cassidy, R-Louisiana, chair of the Senate Health, Education, Labor, and Pensions Committee, the senators in a March 25 letter pressed the FDA to “take immediate action,” citing concerns about women’s safety, fraud risks, and illegal sales of abortion drugs.</p> <p>Cassidy and Sens. Steve Daines, R-Montana; James Lankford, R-Oklahoma; Cindy Hyde-Smith, R-Mississippi; and Lindsey Graham, R-South Carolina, requested records from abortion drug manufacturers Danco Laboratories, GenBioPro and Evita Solutions.</p> <p>“It is unclear how the three FDA-approved chemical abortion drug manufacturers, Danco, GenBioPro, and Evita, ensure that prescribers and pharmacies comply with the few remaining [Mifepristone Risk Evaluation and Mitigation Strategy] requirements, especially when pills are sold online and without the in-person oversight of a medical professional,” the press release from the senators read.</p> <p><strong>U.S. Sen. Josh Hawley investigates abortion drug manufacturers</strong></p> <p>U.S. Sen. Josh Hawley launched his own investigation into abortion drug manufacturers last week, requesting records from Danco Laboratories and GenBioPro.</p> <p>Hawley is concerned that drug companies profited from abortion pills while knowing the risks to women.</p> <p>“Mounting evidence suggests that mifepristone poses grave risks to women,” Hawley wrote in the letter. “Yet your company has continued to profit from the widespread distribution of this drug even as serious questions have emerged about hemorrhage, infection, sepsis, and other dangerous complications associated with its use.”</p> <p>Judge grants $1 murder bail, $2,000 for drug possession for Georgia woman after infant daughter dies</p> <p>A Georgia judge granted a $1 bond for a woman accused of murder after introducing oxycodone into her infant daughter’s system and also ordered a $1,000 bond for each of two drug charges.</p> <p>In late December 2025, Alexia Moore allegedly took eight misoprostol pills when she was between 22 and 24 weeks pregnant and “introduced illegal oxycodone into the infant’s system,” according to the arrest warrant. She gave birth prematurely to a baby girl who died within the hour. </p> <p>Moore was arrested on March 4, facing one count of murder for unlawfully causing the death of the infant with “malice aforethought” and two drug-related charges.</p> <p>Reports circulated blaming Georgia’s pro-life law for the arrest, but the Georgia law does not criminalize women who have abortions — no U.S. state does.</p> <p><strong>Ohio bill would recognize unborn babies with heartbeats with certificate of life</strong></p> <p>A recently proposed Ohio bill would requi